ArticleFrontiers in immunology2026
Ulcerative colitis, but not Crohn's disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammatory bowel disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC), two conditions with distinct immunopathological profiles despite shared inflammatory pathways. Comparative mucosal and systemic immune characterisation across disease subtypes and clinical variables remains limited. This study aimed to map leukocyte dysregulation in tissue and blood from patients with CD and UC compared to controls. Methods: Intestinal tissue and blood samples were obtained from 35 controls and endoscopically active IBD patients, including 54 with CD and 74 with UC. Leukocyte subsets were identified using a 29-marker spectral cytometry panel combining hierarchical gating with unsupervised clustering and dimensionality reduction. Immune composition was stratified by disease location, biological sex, age and endoscopic severity. Results: Hierarchical gating identified 41 mucosal and 42 circulating immune subsets; unsupervised clustering resolved 51 mucosal and 62 blood clusters. Both diseases displayed dysregulated mucosal immunity relative to controls but with distinct signatures: while CD was mainly T-cell biased, UC showed a mixed infiltrate with an increased relative proportion of NK, NKT and IgG Conclusions: UC displayed more prominent subgroup-associated mucosal immune heterogeneity than CD, particularly according to biological sex, age and endoscopic severity. These findings support tissue-resolved patient stratification in UC and highlight the limited sensitivity of blood-based biomarkers to reflect mucosal immune alterations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.